0001528287-20-000001.txt : 20200831 0001528287-20-000001.hdr.sgml : 20200831 20200831133234 ACCESSION NUMBER: 0001528287-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200831 DATE AS OF CHANGE: 20200831 EFFECTIVENESS DATE: 20200831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroPace Inc CENTRAL INDEX KEY: 0001528287 IRS NUMBER: 223550230 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-374490 FILM NUMBER: 201150923 BUSINESS ADDRESS: STREET 1: 455 N. BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6502372700 MAIL ADDRESS: STREET 1: 455 N. BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 D 1 primary_doc.xml X0708 D LIVE 0001528287 NeuroPace Inc 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA CALIFORNIA 94043 6502372700 DELAWARE None None Corporation true Frank Fischer 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Executive Officer Director Rebecca Kuhn 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Executive Officer Mike Favet 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Executive Officer Director Greg Garfield 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Director Joseph Lacob 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Director Evan Norton 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Director Renee Ryan 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Director Nael Kassar 455 N. Bernardo Avenue Mountain View CA CALIFORNIA 94043 Director Vince Burgess 455 N. Bernando Avenue Mountain View CA CALIFORNIA 94043 Director Rishi Gupta 455 N. Bernando Avenue Mountain View CA CALIFORNIA 94043 Director Other Health Care Decline to Disclose 06b false 2020-08-19 false true true (i) Series B' Preferred Stock; Common Stock issuable upon conversion false 0 96385618 69385618 27000000 Total Offering Amount includes conversion of outstanding indebtedness in the amount of $36,385,617.25. false 23 0 663428 0 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries false NeuroPace Inc /s/Rebecca Kuhn Rebecca Kuhn VP, Finance & Administration 2020-08-26